Key Thematic Areas
Challenging unmet medical and societal needs through a comprehensive value chain spanning across Africa.
Manufacturing
Benchmarking manufacturing processes and continuous operational excellences are the core of our capabilities to deliver quality medicines to our general African population. We have key focus areas; active pharmaceutical ingredients (API), oral solid dose (OSD), injectables, biosimilars, and plasma products. Our strength is fueled by early identification of molecules, building robust API processes, and targeting early launch opportunities in key markets through complete backward integration.
Supply chain and core pharma value chain
BAL is a leading, vertically integrated global pharmaceutical formulation development, manufacturing, and marketing company. We are committed to challenging the unmet medical and societal needs through a comprehensive pharmaceutical value chain spanning across the world and Africa. Breakwall Africa Limited has set up a network of subsidiaries, under the Umbrella of BREAKWALL PHARMACEUTICALS AND MEDICAL SUPPLIES (BPMS).
Research and Development
We are a science-driven, innovation –focused company committed to accelerating access to healthcare solutions to patients around the world. Digitalize the core is our approach to simplifying and digitalizing our processes. It is about creating scale without adding complexity. BAL believes in empowering people, therefore, to fulfill its corporate vision and mission, it aims to acquire and retain the best talent across the industry to fully leverage the diversity of respective markets they operate in.
Digitalization, Science and Technology
We are adopting cutting-edge digital technologies to transform our R AND D, Manufacturing, supply chain, and marketing, sales and services. Digital transformation through technology and people transformation is our strategic growth enabler. We are adopting disruptive technology in our value chain to enabling scaling up, increase productivity, and create value. Our digital transformation initiatives are of two kinds: in core pharma value chain and in the patient customer journey extending to patient journey as well. Our digital science initiative helps give impetus to our research and development effort with data and analytics use cases across the development cycle. These used cases are aimed at achieving significant reduction in drug development cycle time, improvement of bio study success rate, cost savings to enable First to market products, accelerating the R AND D timelines.
Consultancy in Health Care
Consultancy in Health Care and programming in shaping the future of Africa. We engage with public officials in a forum dedicated to strengthening public-private dialogue in the pursuit of an economically strong and sovereign Africa.
Mining and green mineral value chain in Africa
Africa possesses a significant share of global mineral reserves- including 92% of platinum, 56% of cobalt, 54% of manganese, and 36% of chromium. These minerals are used to produce green technologies such as electric vehicle (EV) batteries and wind turbines. Currently minerals are largely exported from Africa in their raw states to be refined abroad. Several African countries including Uganda have already developed and adopted policies aimed at developing their mineral value chains, such as export restrictions on raw materials, to develop the minerals sectors, African countries need to attract investment, improve geological mapping and expand their skilled workforce.